<?xml version="1.0" encoding="UTF-8"?>
<p>Other compounds described in our manuscript such as oseltamivir, ribavirin, arbidol, and natural compounds (betulinic acid) proved to have potent in vitro antiviral activity against SARS-CoV-2; still, further studies (preclinical and clinical) are required to confirm their effectiveness as anti-COVID-19 therapeutic agents. Convalescent plasma collected from COVID-19 patients represents a promising therapeutic alternative with immediate results; however, some limitations were noticed in terms of its obtaining and approval for use (the ongoing clinical trials results will confirm its effectiveness).</p>
